vs
KALTURA INC（KLTR）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
KALTURA INC的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.3倍（$45.5M vs $35.5M），KALTURA INC净利率更高（-1.3% vs -304.2%，领先303.0%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -0.1%），KALTURA INC自由现金流更多（$3.5M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 0.8%）
Kaltura Inc是2006年成立、总部位于纽约的软件企业，业务覆盖多个核心领域：网络研讨会与虚拟活动、企业视频内容管理、在线视频平台、教育科技以及云电视软件，可提供视频门户、学习管理系统与内容管理系统扩展插件、虚拟活动与网络研讨会平台、电视流媒体应用等多款产品。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
KLTR vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.5M | $35.5M |
| 净利润 | $-575.0K | $-108.1M |
| 毛利率 | 72.4% | 59.8% |
| 营业利润率 | 1.9% | -304.8% |
| 净利率 | -1.3% | -304.2% |
| 营收同比 | -0.1% | 681.7% |
| 净利润同比 | 91.3% | 39.6% |
| 每股收益（稀释后） | — | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $45.5M | $35.5M | ||
| Q3 25 | $43.9M | $5.2M | ||
| Q2 25 | $44.5M | $19.2M | ||
| Q1 25 | $47.0M | $14.7M | ||
| Q4 24 | $45.6M | $4.5M | ||
| Q3 24 | $44.3M | $26.1M | ||
| Q2 24 | $44.0M | $14.4M | ||
| Q1 24 | $44.8M | $13.8M |
| Q4 25 | $-575.0K | $-108.1M | ||
| Q3 25 | $-2.6M | $-162.3M | ||
| Q2 25 | $-7.8M | $-171.9M | ||
| Q1 25 | $-1.1M | $-202.5M | ||
| Q4 24 | $-6.6M | $-178.9M | ||
| Q3 24 | $-3.6M | $-95.8M | ||
| Q2 24 | $-10.0M | $-97.5M | ||
| Q1 24 | $-11.1M | $-91.4M |
| Q4 25 | 72.4% | 59.8% | ||
| Q3 25 | 70.0% | -183.8% | ||
| Q2 25 | 70.2% | -4.9% | ||
| Q1 25 | 69.7% | -48.0% | ||
| Q4 24 | 70.8% | -181.4% | ||
| Q3 24 | 66.7% | 53.7% | ||
| Q2 24 | 65.1% | 36.2% | ||
| Q1 24 | 63.9% | 19.1% |
| Q4 25 | 1.9% | -304.8% | ||
| Q3 25 | -3.4% | -3327.6% | ||
| Q2 25 | -6.2% | -916.8% | ||
| Q1 25 | -3.4% | -1297.9% | ||
| Q4 24 | -8.3% | -4042.4% | ||
| Q3 24 | -10.1% | -377.1% | ||
| Q2 24 | -19.4% | -697.4% | ||
| Q1 24 | -16.3% | -698.4% |
| Q4 25 | -1.3% | -304.2% | ||
| Q3 25 | -6.0% | -3135.3% | ||
| Q2 25 | -17.4% | -894.2% | ||
| Q1 25 | -2.4% | -1373.3% | ||
| Q4 24 | -14.5% | -3935.5% | ||
| Q3 24 | -8.1% | -367.5% | ||
| Q2 24 | -22.7% | -676.6% | ||
| Q1 24 | -24.8% | -662.4% |
| Q4 25 | — | $-0.17 | ||
| Q3 25 | $0.02 | $-0.36 | ||
| Q2 25 | $-0.05 | $-0.41 | ||
| Q1 25 | — | $-0.50 | ||
| Q4 24 | — | $-0.56 | ||
| Q3 24 | $0.02 | $-0.34 | ||
| Q2 24 | $-0.07 | $-0.40 | ||
| Q1 24 | — | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $51.9M | $743.3M |
| 总债务越低越好 | $29.3M | $9.6M |
| 股东权益账面价值 | $6.3M | $1.1B |
| 总资产 | $164.7M | $1.5B |
| 负债/权益比越低杠杆越低 | 4.63× | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $51.9M | $743.3M | ||
| Q3 25 | $72.2M | $659.8M | ||
| Q2 25 | $71.2M | $525.1M | ||
| Q1 25 | $62.9M | $500.5M | ||
| Q4 24 | $81.3M | $594.4M | ||
| Q3 24 | $77.7M | $427.6M | ||
| Q2 24 | $68.3M | $474.3M | ||
| Q1 24 | $68.9M | $296.3M |
| Q4 25 | $29.3M | $9.6M | ||
| Q3 25 | $30.6M | $11.9M | ||
| Q2 25 | $31.3M | $14.2M | ||
| Q1 25 | $31.9M | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | $33.3M | $20.5M | ||
| Q2 24 | $33.7M | $22.9M | ||
| Q1 24 | $34.1M | — |
| Q4 25 | $6.3M | $1.1B | ||
| Q3 25 | $17.7M | $1.0B | ||
| Q2 25 | $17.0M | $919.1M | ||
| Q1 25 | $22.7M | $933.9M | ||
| Q4 24 | $24.4M | $1.0B | ||
| Q3 24 | $24.1M | $524.6M | ||
| Q2 24 | $23.5M | $584.4M | ||
| Q1 24 | $25.1M | $401.2M |
| Q4 25 | $164.7M | $1.5B | ||
| Q3 25 | $172.6M | $1.4B | ||
| Q2 25 | $169.4M | $1.3B | ||
| Q1 25 | $172.8M | $1.3B | ||
| Q4 24 | $181.3M | $1.4B | ||
| Q3 24 | $178.6M | $726.5M | ||
| Q2 24 | $171.3M | $775.9M | ||
| Q1 24 | $173.1M | $557.8M |
| Q4 25 | 4.63× | 0.01× | ||
| Q3 25 | 1.73× | 0.01× | ||
| Q2 25 | 1.85× | 0.02× | ||
| Q1 25 | 1.41× | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | 1.38× | 0.04× | ||
| Q2 24 | 1.43× | 0.04× | ||
| Q1 24 | 1.36× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.6M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $3.5M | $-47.3M |
| 自由现金流率自由现金流/营收 | 7.7% | -133.1% |
| 资本支出强度资本支出/营收 | 0.3% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $13.9M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $3.6M | $-46.1M | ||
| Q3 25 | $9.3M | $-117.4M | ||
| Q2 25 | $2.7M | $-76.4M | ||
| Q1 25 | $-1.0M | $-132.0M | ||
| Q4 24 | $4.3M | $-115.4M | ||
| Q3 24 | $10.7M | $-59.2M | ||
| Q2 24 | $-1.6M | $-82.2M | ||
| Q1 24 | $-1.1M | $-102.3M |
| Q4 25 | $3.5M | $-47.3M | ||
| Q3 25 | $9.2M | $-117.6M | ||
| Q2 25 | $2.5M | $-79.6M | ||
| Q1 25 | $-1.3M | $-133.8M | ||
| Q4 24 | $4.2M | $-116.7M | ||
| Q3 24 | $10.6M | $-63.8M | ||
| Q2 24 | $-1.8M | $-83.4M | ||
| Q1 24 | $-1.2M | $-109.0M |
| Q4 25 | 7.7% | -133.1% | ||
| Q3 25 | 20.9% | -2272.5% | ||
| Q2 25 | 5.7% | -413.9% | ||
| Q1 25 | -2.9% | -907.4% | ||
| Q4 24 | 9.2% | -2567.7% | ||
| Q3 24 | 23.9% | -244.6% | ||
| Q2 24 | -4.2% | -578.5% | ||
| Q1 24 | -2.8% | -789.9% |
| Q4 25 | 0.3% | 3.5% | ||
| Q3 25 | 0.3% | 4.7% | ||
| Q2 25 | 0.3% | 16.4% | ||
| Q1 25 | 0.6% | 12.4% | ||
| Q4 24 | 0.2% | 28.6% | ||
| Q3 24 | 0.2% | 17.5% | ||
| Q2 24 | 0.5% | 8.2% | ||
| Q1 24 | 0.2% | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KLTR
| Subscription | $42.7M | 94% |
| Professional Services | $2.9M | 6% |
RXRX
暂无分部数据
